Ananda Pharma has begun participant screening for a Phase 2 [...]

ReproNovo has dosed the first participant in a European Phase [...]

The first patients have been dosed with MP0712, a DLL3-targeted [...]

Xeltis has passed the halfway enrolment mark in its US [...]

Abivax has reported positive topline results from Part 2 of [...]

Telix Pharmaceuticals has received FDA agreement on the protocol and [...]

SERB has completed its €115 million licensing agreement with Hansa [...]

Remepy has published new peer-reviewed findings showing that its investigational [...]

Inocras and AimedBio have formed a strategic partnership to integrate [...]

Poolbeg Pharma has secured a South African patent covering the [...]